Skip to main content
. 2020 Aug 28;100(1):109–118. doi: 10.1111/aogs.13976

TABLE 2.

Baseline characteristics. Data are presented as n (%), mean (SD) or median (range). If data are not available from all women, the denominator is noted separately

Temporizing management Immediate delivery
(n = 30) (n = 26)
At start of pregnancy
Maternal age, yr (mean, SD) 29.2 (4.6) 28.7 (5.4)
Ethnicity
Caucasian 21 (70%) 15 (58%)
Other 9 (30%) 11 (42%)
Highest level of education
Primary or secondary school 0 (0%) 0 (0%)
Lower/medium professional education 6 (20%) 6 (21%)
Higher professional education/ university 2 (7%) 2 (8%)
Other/unknown 22 (73%) 16 (61%)
Current pregnancy:
Singleton 29 (97%) 22 (85%)
Twin 1 (3%) 3 (12%)
Triplet 0 (0%) 1 (4%)
Parity
Nulliparous 22 (73%) 12 (46%)
Primi‐ and multiparous 8 (27%) 14 (54%)
Preeclampsia in previous pregnancy a 5/8 (63%) 9/14 (64%)
Blood pressure, at booking (mm Hg)
Systolic 118 (9.6) 135 (22.9)
Diastolic 74 (8.1) 80 (16.4)
BMI at booking >35 1 (3%) 4 (15%)
At start study
Gestational age (days) 214 (12.6) 216 (10.7)
Inclusion for: b
Clinical symptoms 23 (77%) 17 (68%)
Laboratory abnormalities 10 (33%) 11 (42%)
Severe hypertension 20 (67%) 12 (46%)
Proteinuria (>300 mg/day) 28 (100%) 25 (100%)
Protein‐to‐creatinine ratio (mg/mmol) 184 (93‐460) 73.5 (28‐174)
Blood pressure, at inclusion (mm Hg)
Systolic 154 (30.1) 153 (17.0)
Diastolic 99 (10.8) 93 (10.6)
Smoking
No 24 (80%) 18 (69%)
Stopped in 1st or 2nd trimester 4/29 (14%) 4/25 (16%)
Unknown 2 (7%) 4 (15%)
Antihypertensive medication at study entry
Oral 27/29 (93%) 22 (85%)
Intravenous 15/29 (52%) 13/24 (54%)
Anticonvulsive medication (including magnesium sulfate) 25/26 (96%)

20 (77%)

BMI, body mass index.

a

Numerator: primi‐ and multiparous women.

b

Multiple inclusion criteria possible.